Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
- Resource Type
- Article
- Source
- The Lancet; 20220101, Issue: Preprints
- Subject
- Language
- ISSN
- 01406736; 1474547X